118
- Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to
defi ning functional ability in ankylosing spondylitis: the development of the bath ankylosing
spondylitis functional index. J Rheumatol. 1994;21(12):2281–5. - Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, et al. Ankylosing spondylitis
disease activity score (ASDAS): defi ning cut-off values for disease activity states and
improvement scores. Ann Rheum Dis. 2011;70(1):47–53. - Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham vascu-
litis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87(11):671–8. - Whiting O’Keefe QE, Stone JH, Hellmann DB. Validity of a vasculitis activity index for
systemic necrotizing vasculitis. Arthritis Rheum. 1999;42:2365–71. - Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al. A disease-
specifi c activity index for Wegener’s granulomatosis: modifi cation of the Birmingham vascu-
litis activity score. Arthritis Rheum. 2001;44(4):912–20. - Pincus T, Yazici Y, Sokka T. Quantitative measures of rheumatic diseases for clinical research
versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin
Rheumatol. 2007;21(4):601–28. - Wolfe F, Michaud K. The clinical and research signifi cance of the erythrocyte sedimentation
rate. J Rheumatol. 1994;21:1227–37. - Bowling A. Measuring disease: a review of disease-specifi c quality of life measurement
scales, vol. 2. Buckingham: Open University Press; 2001. p. 25–6. - Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
- Ebrahim S, Barer D, Nouri F. Use of the Nottingham Health Profi le with patients after a
stroke. J Epidemiol Community Health. 1986;40(2):166–9. - Meadows K. Patient-reported outcome measures: an overview. Br J Community Nurs.
2011;16(3):146–51. - Pincus T, Yazici Y, Bergman M. Development of a multi-dimensional health assessment
questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol.
2005;23 Suppl 39:S19–28. - Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in
rheumatoid arthritis: a cross-sectional study to evaluate the Bristol rheumatoid arthritis
fatigue multi-dimensional questionnaire, visual analog scales, and numerical rating scales.
Arthritis Care Res. 2010;32:1559–68. - Osterhaus JT. Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-
specifi c work productivity survey (WPS-RA). Arthritis Res Ther. 2009;11:R73. - Pincus T, Swearingen C, Wolfe F. Toward a multidimensional health assessment question-
naire (MDHAQ): assessment of advanced activities of daily living and psychological status
in the patient-friendly health assessment questionnaire format. Arthritis Rheum.
1999;42:2220–30. - Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al.
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-
derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann
Rheum Dis. 2011;70(6):935–42. - Pincus T. Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to
pulse and temperature in acute diseases and blood pressure and cholesterol in long-term
health. Bull NYU Hosp Joint Dis. 2008;66(2):155–65. - El Miedany Y, Palmer D, El Gaafary M. Further analysis of helplessness measurement in
infl ammatory arthritis/spondyloarthritis: the development of the modifi ed rheumatology atti-
tude index. Rheumatology (Oxford). 2010;49(S1):162. - Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Ostergaard M, et al.
Proposal for levels of evidence schema for validation of a soluble biomarker refl ecting
damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and
recommendations for study design. J Rheumatol. 2009;36(8):1792–9. - Biomarkers Defi nition Working Group. Biomarkers and surrogate endpoints: preferred defi -
nitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
Y. El Miedany